Showing 1231-1240 of 1555 results for "".
When the Diagnosis Is Not Glaucoma
https://modernod.com/topics/glaucoma/when-the-diagnosis-is-not-glaucoma/38072/Know the masqueraders.Medical Management of Diabetic Retinopathy
https://modernod.com/mod-issues/2019-june/medical-management-ofdiabetic-retinopathy/37944/Thanks to the development of pharmacotherapies for this disease state, patient outcomes are better than ever.Boost Your Glaucoma Drug Knowledge
https://modernod.com/topics/glaucoma/boost-your-glaucoma-drug-knowledge/37906/It’s helpful to know the treatment options available.Optimizing vision in CXL Patients
https://modernod.com/mod-issues/2020-oct/optimizing-vision-in-cxl-patients/39112/Two optometrists unpack the refractive toolbox.Glucagon-Like Peptide 1 Receptor Agonists and the Eye
https://modernod.com/topics/nutritionpharmaceuticals/glucagon-like-peptide-1-receptor-agonists-and-the-eye/38808/These drugs offer a promising outlook as transformative therapies in glycemic control, weight management, and more, but what effect do they have on our patients’ ocular health?Retina in Review
https://modernod.com/topics/retina/retina-in-review/38713/An overview of the latest developments and findings related to the treatment and management of diseases of the posterior segment.What’s New and What’s Coming in OSD Treatment
https://modernod.com/topics/ocular-surface/whats-new-and-whats-coming-in-osd-treatment/38578/An overview of recent FDA approvals and potential new therapies.- FDA Chief Scott Gottlieb to Resignhttps://modernod.com/news/fda-chief-scott-gottlieb-to-resign/2476349/FDA Commissioner Scott Gottlieb is resigning, ending a tenure at the agency where he approved a flood of new drugs and cheaper copycat pills, and pushed for sharp curbs on e-cigarette use to halt what he called an epidemic of youth use, according to a Bloomberg
- Neurotech Pharmaceuticals Appoints Scott Hunter as Chief Commercial Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-scott-hunter-as-chief-commercial-officer/2481341/Neurotech Pharmaceuticals announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eye care experience across both rare disease and specialty markets. “Scott’s appointment as the company&rsquo
- Ophthalmic Industry Veteran Scott Hunter Passes Awayhttps://modernod.com/news/ophthalmic-industry-veteran-scott-hunter-passes-away/2482564/Longtime ophthalmic industry leader Scott Hunter passed away on December 3, Neurotech announced. Mr. Hunter was the Chief Commercial Officer of Neurotech, a position he held since January 2023. “The entire Neurotech family mourns this loss. On behalf of the Board of Directors, man